Personalized Search
Displaying 561 - 580 of 1074
SOLIRIS is a prescription medicine called a
monoclonal antibody
monoclonal antibody:
A type of protein called an antibody that is engineered to look for a specific substance in the body. There are many kinds of monocloncal antibodies. Each one looks for only one substance. Eculizumab (Soliris) is an monoclonal antibody that may be prescribed to treat patients with paroxysmal…
. SOLIRIS…
Downloadable last updated
.
Information on workplace rights & responsibilities for individuals with
Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria:
(par-uk-SIZ-muhl nok-TURN-uhl hee-muh-gloe-buh-NYOOR-ee-uh) A rare and serious blood disease that causes red blood cells to break apart. Paroxysmal means sudden and irregular. Nocturnal means at night. Hemoglobinuria means hemoglobin in…
Downloadable last updated
.
Review of the range of PNH symptoms based on low blood counts
Downloadable last updated
.
Summary of active surveillance and
supportive care
supportive care:
Care given to improve the quality of life, or comfort, of a person with a chronic illness. Supportive care treats the symptoms rather than the underlying cause of a disease. The goal is to help the patient feel better. Patients with low blood counts may be given blood transfusions as supportive…
MDS treatment options
Downloadable last updated
.
Venclexta® (also known as
Venetoclax
Venetoclax:
Venetoclax is used to treat chronic lymphocytic leukemia or small lymphocytic leukemia in adults. Venetoclax is used alone or in combination with other cancer medicines to treat these conditions.
) is a prescribed oral tablet approved by the Food and
Drug Administration for adult patients with
acute myeloid leukemia
acute myeloid…
Downloadable last updated
.
A Biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly
similar to the already approved brand name biologic (“originator” medication)
Downloadable last updated
.
REBLOZYL® (luspatercept-aamt) was the first erythroid maturation agent (EMA) approved in
2020 by the Food and Drug Administration for the treatment of
anemia
anemia:
(uh-NEE-mee-uh) A condition in which there is a shortage of red blood cells in the bloodstream. This causes a low red blood cell count. Symptoms of anemia are fatigue and tiredness.
in adult patients with…
Downloadable last updated
.
Guidelines for managing your MDS treatment plan with your health care team
Downloadable last updated
.
Summary of FDA-approved medicines for treating high risk MDS and transplantation options
Downloadable last updated
.
ULTOMIRIS® is a prescription medicine called a
monoclonal antibody
monoclonal antibody:
A type of protein called an antibody that is engineered to look for a specific substance in the body. There are many kinds of monocloncal antibodies. Each one looks for only one substance. Eculizumab (Soliris) is an monoclonal antibody that may be prescribed to treat patients with paroxysmal…
.…
Downloadable last updated
.
This guide provides information about
clinical trials
clinical trials:
Clinical research is at the heart of all medical advances, identifying new ways to prevent, detect or treat disease. If you have a bone marrow failure disease, you may want to consider taking part in a clinical trial, also called a research study.
Understanding Clinical Trials
Clinical…
and gives you some things…
Downloadable last updated
.
MarrowForums provides free discussion forums for patients with
bone marrow failure
bone marrow failure:
A condition that occurs when the bone marrow stops making enough healthy blood cells. The most common of these rare diseases are aplastic anemia, myelodysplastic syndromes (MDS) and paroxysmal nocturnal hemoglobinuria (PNH). Bone marrow failure can be acquired (begin any time in life…
Downloadable last updated
.
FABHALTA, a complement factor B inhibitor, is the first oral medication approved to treat
adults with
paroxysmal nocturnal hemoglobinuria
paroxysmal nocturnal hemoglobinuria:
(par-uk-SIZ-muhl nok-TURN-uhl hee-muh-gloe-buh-NYOOR-ee-uh) A rare and serious blood disease that causes red blood cells to break apart. Paroxysmal means sudden and irregular. Nocturnal means at night.…
Downloadable last updated
.
Summary of the common side effects of MDS treatments and tips for managing them
Downloadable last updated
.
Review of the range of MDS symptoms based on low blood counts
Downloadable last updated
.
INQOVI® (previously known as ASTX727) is a prescribed oral tablet combination of
decitabine
decitabine:
It works by reducing the amount of methylation in the body. Methylation is a process that acts like a switch to turn off or “silence” genes in certain cells. When these genes (called tumor suppressor genes) are turned off, MDS cells and cancer cells can grow freely. Decitabine is…
Downloadable last updated
.
A list of organizations & programs that may provide financial resources & other assistance
Downloadable last updated
.
